Mrs. Margaret Kota, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10674 Prospect St, Gowanda, NY 14070 Phone: 716-532-3325 |
Mrs. Melanie Laurie Della Vella, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10674 Prospect St, Gowanda, NY 14070 Phone: 716-532-3325 |
Milestone Speech Therapy Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 26 W Main St, Gowanda, NY 14070 Phone: 716-698-2552 |
Lisa Marie Coudrey Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 63 W Main St, Gowanda, NY 14070 Phone: 716-698-2552 |
Jessica Shean Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Miller St, Gowanda, NY 14070 Phone: 716-532-5700 |
Jennifer Jane Lurz Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3499 Foster Road, Gowanda, NY 14070 Phone: 716-532-2899 |
News Archive
The U.S. Chamber of Commerce Business Civic Leadership Center (BCLC) is recognizing Health Care Service Corporation (HCSC) for its outstanding work with community service. The BCLC has named HCSC as a finalist for its Corporate Citizenship Award in the category of U.S. Community Service. The U.S. Chamber of Commerce is the world's largest business federation and HCSC is the country's largest customer-owned health insurer operating Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas.
Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.
Among children with kidney disease, certain races are less likely to get kidney transplants and are more likely to die than other races, according to two studies from Emory University that were presented during the American Society of Nephrology's Annual Kidney Week.
RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI's IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.
› Verified 3 days ago